Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BIO Likes EU Model For Follow-On Biologics; Standards Are “Appropriate”

Executive Summary

The European Union approach to follow-on biologic products sets an "appropriate" standard, the Biotechnology Industry Organization said

You may also be interested in...



BIO Begins Search For New President; Feldbaum To Step Down By End Of Year

The Biotechnology Industry Organization will begin the process of selecting a new president at its Feb. 23 board meeting in New York

BIO Begins Search For New President; Feldbaum To Step Down By End Of Year

The Biotechnology Industry Organization will begin the process of selecting a new president at its Feb. 23 board meeting in New York

EU Drug Law Gets Pfizer Support; More Exclusivity “Trades-Off” With Generics

Pfizer CEO Hank McKinnell supports European drug regulation legislation that provides extended marketing exclusivity and speeds the entry of generics

Related Content

UsernamePublicRestriction

Register

PS043072

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel